
Bahar Alawi Craigo
Examiner (ID: 5706)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1759, 1699, 4131, 1623, 1673 |
| Total Applications | 926 |
| Issued Applications | 371 |
| Pending Applications | 113 |
| Abandoned Applications | 462 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16482421
[patent_doc_number] => 20200376021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => ISOLATED IMPERATA CYLINDRICA POLYSACCHARIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967391
[patent_app_country] => US
[patent_app_date] => 2019-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967391 | ISOLATED IMPERATA CYLINDRICA POLYSACCHARIDE AND USE THEREOF | Feb 1, 2019 | Abandoned |
Array
(
[id] => 17148366
[patent_doc_number] => 11141417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Voriconazole inclusion complexes
[patent_app_type] => utility
[patent_app_number] => 16/256703
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4263
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16256703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/256703 | Voriconazole inclusion complexes | Jan 23, 2019 | Issued |
Array
(
[id] => 15264697
[patent_doc_number] => 20190381082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => APPLICATION OF VERBASCOSIDE IN TREATMENT AND PREVENTION OF TYPE II DIABETIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/236403
[patent_app_country] => US
[patent_app_date] => 2018-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16236403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/236403 | APPLICATION OF VERBASCOSIDE IN TREATMENT AND PREVENTION OF TYPE II DIABETIC KIDNEY DISEASE | Dec 28, 2018 | Abandoned |
Array
(
[id] => 16612124
[patent_doc_number] => 20210030777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => TOPICAL FORMUATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/043068
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043068 | TOPICAL FORMUATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF | Dec 27, 2018 | Abandoned |
Array
(
[id] => 14621715
[patent_doc_number] => 20190224225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/229338
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229338 | Esters of 2-deoxy-monosaccharides with anti proliferative activity | Dec 20, 2018 | Issued |
Array
(
[id] => 18383332
[patent_doc_number] => 11654096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Xyloside derivatives of resveratrol for use thereof in cosmetics
[patent_app_type] => utility
[patent_app_number] => 16/955616
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8592
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955616 | Xyloside derivatives of resveratrol for use thereof in cosmetics | Dec 19, 2018 | Issued |
Array
(
[id] => 16569081
[patent_doc_number] => 20210008087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION
[patent_app_type] => utility
[patent_app_number] => 16/956511
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956511 | Composition comprising HMOs for preventing or reducing nociception | Dec 18, 2018 | Issued |
Array
(
[id] => 14467719
[patent_doc_number] => 20190185502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/222125
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222125 | Glucosamine derivatives and pharmaceutical uses thereof | Dec 16, 2018 | Issued |
Array
(
[id] => 16946652
[patent_doc_number] => 20210205343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Compounds for Treating and Preventing Extracellular Histone Mediated Pathologies
[patent_app_type] => utility
[patent_app_number] => 16/770987
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770987 | Compounds for treating and preventing extracellular histone mediated pathologies | Dec 13, 2018 | Issued |
Array
(
[id] => 17512558
[patent_doc_number] => 11291675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => 6'-sialyllactose for use in the treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 16/770402
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5546
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770402 | 6'-sialyllactose for use in the treatment of hearing loss | Dec 6, 2018 | Issued |
Array
(
[id] => 17307336
[patent_doc_number] => 11208428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Method for producing P
[patent_app_type] => utility
[patent_app_number] => 16/206380
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8962
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/206380 | Method for producing P | Nov 29, 2018 | Issued |
Array
(
[id] => 16435680
[patent_doc_number] => 20200353005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => HUMAN MILK OLIGOSACCHARIDES FOR TREATING MIGRAINE
[patent_app_type] => utility
[patent_app_number] => 16/770336
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770336 | Human milk oligosaccharides for treating migraine | Nov 29, 2018 | Issued |
Array
(
[id] => 16375053
[patent_doc_number] => 20200323895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease
[patent_app_type] => utility
[patent_app_number] => 16/765420
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765420 | Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease | Nov 26, 2018 | Abandoned |
Array
(
[id] => 18801539
[patent_doc_number] => 11834691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Process for purification of a sialic acid from a fermentation broth
[patent_app_type] => utility
[patent_app_number] => 16/765407
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18232
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765407 | Process for purification of a sialic acid from a fermentation broth | Oct 30, 2018 | Issued |
Array
(
[id] => 16190860
[patent_doc_number] => 20200231709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => ?-1,3-1,6-GLUCAN POWDER, GLUCAN-CONTAINING COMPOSITION, METHOD FOR PRODUCING ?-1,3-1,6-GLUCAN POWDER, INCLUSION COMPLEX, METHOD FOR PRODUCING INCLUSION COMPLEX, AND METHOD FOR RECOVERING GUEST MOLECULE
[patent_app_type] => utility
[patent_app_number] => 16/754952
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754952 | B-1,3-1,6-glucan powder, glucan-containing composition, method for producing B-1,3-1,6-glucan powder, inclusion complex, method for producing inclusion complex, and method for recovering guest molecule | Oct 9, 2018 | Issued |
Array
(
[id] => 16791673
[patent_doc_number] => 20210121490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => AGENT FOR PREVENTING OR AMELIORATING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/756978
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756978 | Agent for preventing or ameliorating alzheimer's disease | Oct 2, 2018 | Issued |
Array
(
[id] => 15711281
[patent_doc_number] => 20200102406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => AMINE FUNCTIONALIZED CHITIN FOR REMOVING MUNITIONS COMPOUNDS FROM SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 16/144954
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144954 | AMINE FUNCTIONALIZED CHITIN FOR REMOVING MUNITIONS COMPOUNDS FROM SOLUTIONS | Sep 26, 2018 | Abandoned |
Array
(
[id] => 16267292
[patent_doc_number] => 20200268779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/651145
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651145 | USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION | Sep 26, 2018 | Abandoned |
Array
(
[id] => 17451831
[patent_doc_number] => 11266667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => ABX196 for use in the treatment of bladder cancer
[patent_app_type] => utility
[patent_app_number] => 16/647379
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5896
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647379 | ABX196 for use in the treatment of bladder cancer | Sep 12, 2018 | Issued |
Array
(
[id] => 14016423
[patent_doc_number] => 20190070205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Compounds for Use in Wound Healing and Angiogenesis
[patent_app_type] => utility
[patent_app_number] => 16/122087
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122087 | Compounds for use in wound healing and angiogenesis | Sep 4, 2018 | Issued |